Cargando…
First In-Mouse Development and Application of a Surgically Relevant Xenograft Model of Ovarian Carcinoma
PURPOSE: Preclinical models of epithelial ovarian cancer have not been exploited to evaluate the clinical standard combination therapy of surgical debulking with follow-up chemotherapy. As surgery is critical to patient survival, here we establish a combined surgical/chemotherapy xenograft model of...
Autores principales: | Helland, Øystein, Popa, Mihaela, Vintermyr, Olav K., Molven, Anders, Gjertsen, Bjørn Tore, Bjørge, Line, McCormack, Emmet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3942384/ https://www.ncbi.nlm.nih.gov/pubmed/24594904 http://dx.doi.org/10.1371/journal.pone.0089527 |
Ejemplares similares
-
The HDACi Panobinostat Shows Growth Inhibition Both In Vitro and in a Bioluminescent Orthotopic Surgical Xenograft Model of Ovarian Cancer
por: Helland, Øystein, et al.
Publicado: (2016) -
CD24-targeted fluorescence imaging in patient-derived xenograft models of high-grade serous ovarian carcinoma
por: Kleinmanns, Katrin, et al.
Publicado: (2020) -
Humanized Ovarian Cancer Patient-Derived Xenografts for Improved Preclinical Evaluation of Immunotherapies
por: Kleinmanns, Katrin, et al.
Publicado: (2022) -
Phenotypic Characterization by Mass Cytometry of the Microenvironment in Ovarian Cancer and Impact of Tumor Dissociation Methods
por: Anandan, Shamundeeswari, et al.
Publicado: (2021) -
CD24-targeted intraoperative fluorescence image-guided surgery leads to improved cytoreduction of ovarian cancer in a preclinical orthotopic surgical model
por: Kleinmanns, Katrin, et al.
Publicado: (2020)